Summary
The Scandinavian Candesartan Acute Stroke Trial [SCAST; NCT00120003] showed that routine blood pressure (BP)-lowering treatment in patients with acute stroke and elevated BP had no benefit and could have a potentially harmful effect.
- Cerebrovascular Disease
- Hypertensive Disease Clinical Trials
- © 2011 MD Conference Express
Tools
Table of contents
Cited By...
- No citing articles found.